An in Situ Crosslinked Compression Coat Comprised of Pectin and Calcium Chloride for Colon-Specific Delivery of Indomethacin

Xiuli Wei,Yi Lu,Jianping Qi,Baojian Wu,Jian Chen,Huinan Xu,Wei Wu
DOI: https://doi.org/10.3109/10717544.2013.879965
IF: 6.819
2014-01-01
Drug Delivery
Abstract:The use of pectin for colon-specific drug delivery has been extensively investigated; however, when used alone, pectin is often compromised due to its high solubility. This study explored the feasibility of using an in situ compression-coated crosslinking system, composed of pectin and calcium chloride, for colon-specific drug delivery. A pectin/calcium chloride (P/Ca) coating was compressed onto a core tablet. The colon specificity of the compression-coated tablet was verified by dissolution, pharmacokinetics and scintigraphy with Tc-99m labeling. The in situ pectin and calcium chloride gel slowed the release of indomethacin. The lag time varied between 3 h and 7 h depending on the amount of calcium chloride and the coating weight. Pectinase triggered the release of indomethacin from the compression-coated tablet, which was then accelerated by the calcium chloride in the coating layer. The compression-coated tablet had a prolonged t(max) and apparent t(1/2), as well as a decreased C-max and AUC(0-t), compared with the core tablet counterpart. Evaluation with gamma-scintigraphy verified colon-specific delivery of the compression-coated tablet. In conclusion, the P/Ca in situ crosslinking system worked well for colon-specific drug delivery.
What problem does this paper attempt to address?